HI TECH PHARMACAL CO INC - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - December 7, 2012

Attached files
FileFilename
EX-31.1 - EX-31.1 - HI TECH PHARMACAL CO INCd399017dex311.htm
EX-31.2 - EX-31.2 - HI TECH PHARMACAL CO INCd399017dex312.htm
EX-32 - EX-32 - HI TECH PHARMACAL CO INCd399017dex32.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR51.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR33.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR52.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR14.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR30.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR44.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR26.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR47.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR39.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR11.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR22.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR41.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR20.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR46.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR25.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR45.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR24.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR42.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR19.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR36.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR35.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR12.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR53.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR18.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR43.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR10.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR54.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR13.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR32.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR15.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR31.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR56.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR37.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR55.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR48.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR16.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR17.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR21.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR28.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR50.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR34.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR27.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR38.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR40.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR23.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR49.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR9.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR1.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR4.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR3.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR5.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR2.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR8.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR6.htm
XML - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCR7.htm
10-Q - FORM 10-Q - HI TECH PHARMACAL CO INCd399017d10q.htm
EXCEL - IDEA: XBRL DOCUMENT - HI TECH PHARMACAL CO INCFinancial_Report.xls
v2.4.0.6
Intangible Assets (Tables)
 6 Months Ended
Oct. 31, 2012
Goodwill and Intangible Assets Disclosure [Abstract]  
Components of net intangible assets

The components of net intangible assets are as follows:

 

                                         
    October 31, 2012     April 30, 2012        
    Gross Carrying
Amount		     Accumulated
Amortization		     Gross Carrying
Amount		     Accumulated
Amortization		     Amortization Period  

Tussicaps® intangible assets

   $ 22,126,000     $ (3,486,000 )    $ 22,126,000     $ (1,992,000 )      5-10 years  

ECR intangible assets

     7,334,000       (2,191,000 )      7,334,000       (1,828,000 )      10 years  

Mag-Ox® intangible assets

     4,100,000       (1,093,000 )      4,100,000       (888,000 )      10 years  

Clobetasol intangible asset

     4,000,000       (1,000,000 )      4,000,000       (800,000 )      10 years  

Orbivan® and Zolvit® intangible assets

     3,577,000       (750,000 )      3,477,000       (463,000 )      3-10 years  

Sinus Buster® intangible assets

     2,513,000       (130,000 )      2,513,000       —         10 years  

Zolpimist® intangible assets

     3,000,000       (656,000 )      3,000,000       (469,000 )      7-10 years  

Zostrix® intangible assets

     5,354,000       (3,552,000 )      5,354,000       (3,179,000 )      3-11.5 years  

KVK License intangible assets

     1,500,000       —         1,500,000       —         10 years  

Midlothian intangible assets

     1,011,000       (401,000 )      1,011,000       (342,000 )      3-10 years  

Vosol® and Vosol® HC intangible assets

     700,000       (333,000 )      700,000       (298,000 )      10 years  

Partnered ANDA intangible assets

     375,000       —         375,000       —         10 years  

Other intangible assets

     1,705,000       (1,063,000 )      1,705,000       (878,000 )      0.5-10 years  
   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

  
    $ 57,295,000     $ (14,655,000 )    $ 57,195,000     $ (11,137,000 )         
   

 

 

    

 

 

    

 

 

    

 

 

          

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by HI TECH PHARMACAL CO INC and has no official or unofficial affiliation with HI TECH PHARMACAL CO INC


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.